Impact of CDA Dynamics on Clinical Outcome of Patients With AML or High‐Risk MDS Treated With Nucleoside AnalogsErwann Collomb, Geoffroy Venton, Raphaëlle Fanciullino et al.|Hematological Oncology|2025Cited by 0
Author response for "Impact of CDA Dynamics on Clinical Outcome of Patients With AML or High‐Risk MDS Treated With Nucleoside Analogs"Erwann Collomb, Geoffroy Venton, Julien Colle et al.|Unknown|2025Cited by 0
Predicting the toxicity-efficacy ratio of venetoclax in real-world patientsLoïc Osanno, Raphaëlle Fanciullino, Lucy Brocque et al.|Annals of Hematology|2025Cited by 0